These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6629280)

  • 1. [Therapy of endocrine diseases in childhood and adolescence. 2. Connatal athyreosis. 3. Diabetes insipidus neurohormonalis].
    Butenandt O
    Fortschr Med; 1983 Sep; 101(34):1497-500. PubMed ID: 6629280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 1-desamino-8-D-arginine vasopressin (DDAVP) in the management of neurogenic diabetes insipidus (multiple etiologies in pediatric patients).
    Brown DR; Uden DL
    Minn Med; 1979 Jun; 62(6):427-32. PubMed ID: 492086
    [No Abstract]   [Full Text] [Related]  

  • 3. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity.
    Ng SM; Wong SC; Didi M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):155-9. PubMed ID: 15212659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences with the synthetic vasopressin derivative 1-desamino-8-D-arginine vasopressin (DDAVP) in the therapy of diabetes insipidus].
    Schrader D; Frahm H; Freisenhausen HD; Lüdecke D; Krüger HP
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1909-12. PubMed ID: 1030134
    [No Abstract]   [Full Text] [Related]  

  • 6. [Germinoma: a rare cerebral tumor causing central diabetes insipidus in childhood].
    Zanetta F; Di Dio G; Savastio S; Saccagno A; Petri A; Bellone S; Maghnie M; Bona G
    Minerva Pediatr; 2008 Feb; 60(1):129-33. PubMed ID: 18277371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Panminerva Med; 1998 Jun; 40(2):103-6. PubMed ID: 9689829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The therapy of congenital hypothyroidism].
    Tatò L; Antoniazzi F; Costantini E; Zamboni G; Bertoldi C
    Ann Ist Super Sanita; 1994; 30(3):325-8. PubMed ID: 7879999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regression of a massive hydronephrosis in familial central diabetes insipidus treated with Adiuretin].
    Kruse K
    Monatsschr Kinderheilkd; 1984 Aug; 132(8):612-4. PubMed ID: 6482884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DDAVP in the treatment of acute neurosurgical diabetes insipidus].
    Zancaner F; Griner A; Galante E
    Minerva Med; 1984 Apr; 75(18):1063-7. PubMed ID: 6728257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes insipidus: clinical and basic aspects.
    Majzoub JA; Srivatsa A
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():60-5. PubMed ID: 17261971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with congenital hypothyroidism and their siblings: do they really differ?
    Rovet JF
    Pediatrics; 2005 Jan; 115(1):e52-7. PubMed ID: 15629966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating congenital hypothyroidism: maximum age limit up to which a socially compatible child is expected.
    Kundu R; Chakrabartty S
    J Indian Med Assoc; 1996 Mar; 94(3):96-8. PubMed ID: 8810204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel therapeutic paradigm to treat congenital hypothyroidism.
    Mathai S; Cutfield WS; Gunn AJ; Webster D; Jefferies C; Robinson E; Hofman P
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):142-7. PubMed ID: 18598275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of therapeutic effect of the growth of children with hypothyroidism.
    Bajracharya BL; Baral MR; Thapa Chhetri P
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):329-33. PubMed ID: 18603928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of vasopressin analogue DDAVP in patients with postoperative diabetes insipidus (author's transl)].
    Kubota T; Kashiwara K; Ito H; Tani K; Yamamoto S
    No To Shinkei; 1981 Jun; 33(3):617-23. PubMed ID: 7259900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laurence-Moon-Biedl syndrome associated with diabetes insipidus neurohormonalis.
    Koepp P
    Eur J Pediatr; 1975 Dec; 121(1):59-62. PubMed ID: 1213037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of physical and mental development of children with aplasia, hypoplasia and ectopy of the thyroid gland.
    Pniewska-Siark B; Jeziorowska A; Bobeff I; Lewiński A
    Endocr Regul; 2006 Mar; 40(1):7-14. PubMed ID: 16964962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus].
    Radó J; Pató E
    Orv Hetil; 1983 May; 124(22):1323-6. PubMed ID: 6877810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.